1. INTRODUCTION {#acm212228-sec-0001}
===============

The Canadian Partnership for Quality Radiotherapy (CPQR) is an alliance among the three key national professional organizations involved in the delivery of radiation treatment in Canada: the Canadian Association of Radiation Oncology (CARO), the Canadian Organization of Medical Physicists (COMP), and the Canadian Association of Medical Radiation Technologists (CAMRT). Financial and strategic backing is provided by the federal government through the Canadian Partnership Against Cancer (CPAC), a national resource for advancing cancer prevention and treatment. The mandate of the CPQR is to support the universal availability of high‐quality and safe radiotherapy for all Canadians through system performance improvement and the development of consensus‐based guidelines and indicators to aid in radiation treatment program development and evaluation.

This document contains detailed performance objectives and safety criteria for Kilovoltage X Ray Radiotherapy Machines. Please refer to the overarching document Technical Quality Control Guidelines for Canadian Radiation Treatment Centres[1](#acm212228-bib-0001){ref-type="ref"} for a programmatic overview of technical quality control, and a description of how the performance objectives and criteria listed in this document should be interpreted.

All information contained in this document is intended to be used at the discretion of each individual center to help guide quality and safety program improvement. There are no legal standards supporting this document; specific federal or provincial regulations and license conditions take precedence over the content of this document.

2. SYSTEM DESCRIPTION {#acm212228-sec-0002}
=====================

Kilovoltage radiotherapy units, although eclipsed first by ⁶⁰Co irradiators and then by linear accelerators, remain useful in the mix of energies available to a radiotherapy program. Low‐energy X ray beams have application in the treatment of skin lesions and shallow tumors. The quality assurance program for the kilovoltage units must match the rigor of that for the most modern irradiators and is every bit as important in order to safely deliver an accurate dose to the patient for those lesions they are appropriate to treat.

Application of kilovoltage radiotherapy is divided into two categories based on the chosen tube voltage. The lower energy range (the "superficial" range; X ray tube potentials of 30 kVp or 40 kVp to 100 kVp and tube currents of a few milliamperes) is used to treat surface lesions. Filtration of up to 6 mm of Al is added to remove the very low energy photons and "harden the beam." Applicator cones, attached directly to the tube‐housing head, are the usual method by which the irradiation area is defined. Variable collimators are also available on some units and require additional quality control tasks over those performed for applicators. Treatment is performed at short source‐to‐surface distance (SSD) (e.g., less than 20 cm) and the lesion depth must be less than a few millimeters. Therefore, the "kilovoltage" range is selected when surface to shallow lesions are treated. In so doing, tissue greater than that at a moderate depth is spared when treating surface lesions.

"Orthovoltage" therapy refers to radiation treatment using X ray tube potentials in the 100--300 kVp range, although 200−300 kVp may be the more practical specification. This deeper radiotherapy equipment uses beam currents of up to 20 mA and applied filtration equivalent to produce half‐value layer (HVL) values of 0.1--4 mm Cu. Coned applicators or movable diaphragms are used to define these beams. While coned applicators may be constructed mostly of metal (e.g., Cu), they have a clear plastic end to aid in viewing the target region. Hence, attention must be given to the integrity of the plastic portion. The depth dose distribution in the orthovoltage energy range is dependent on factors such as kVp, HVL, SSD, and field size. Maximum dose occurs close to the skin, with 90% of the dose being delivered within a tissue depth (water depth) of 2 cm.

Detailed descriptions of various types of kilovoltage X ray radiotherapy machines and various quality control tests have been published in the literature.[2](#acm212228-bib-0002){ref-type="ref"}, [3](#acm212228-bib-0003){ref-type="ref"}, [4](#acm212228-bib-0004){ref-type="ref"}, [5](#acm212228-bib-0005){ref-type="ref"}, [6](#acm212228-bib-0006){ref-type="ref"}, [7](#acm212228-bib-0007){ref-type="ref"}, [8](#acm212228-bib-0008){ref-type="ref"}, [9](#acm212228-bib-0009){ref-type="ref"}, [10](#acm212228-bib-0010){ref-type="ref"}, [11](#acm212228-bib-0011){ref-type="ref"}, [12](#acm212228-bib-0012){ref-type="ref"}, [13](#acm212228-bib-0013){ref-type="ref"}, [14](#acm212228-bib-0014){ref-type="ref"}, [15](#acm212228-bib-0015){ref-type="ref"}, [16](#acm212228-bib-0016){ref-type="ref"}, [17](#acm212228-bib-0017){ref-type="ref"}, [18](#acm212228-bib-0018){ref-type="ref"}, [19](#acm212228-bib-0019){ref-type="ref"}, [20](#acm212228-bib-0020){ref-type="ref"}, [21](#acm212228-bib-0021){ref-type="ref"}, [22](#acm212228-bib-0022){ref-type="ref"}, [23](#acm212228-bib-0023){ref-type="ref"}, [24](#acm212228-bib-0024){ref-type="ref"}, [25](#acm212228-bib-0025){ref-type="ref"}, [26](#acm212228-bib-0026){ref-type="ref"}

3. RELATED TECHNICAL QUALITY CONTROL GUIDELINES {#acm212228-sec-0003}
===============================================

In order to comprehensively assess kilovoltage X ray radiotherapy machines performance, additional guideline tests as outlined in related CPQR Technical Quality Control (TQC) guidelines must also be completed and documented, as applicable. Related TQC guidelines, available at cpqr.ca, include: Safety SystemsMajor Dosimetry Equipment

4. TEST TABLES (TABLES [1](#acm212228-tbl-0001){ref-type="table-wrap"}, [2](#acm212228-tbl-0002){ref-type="table-wrap"}, [3](#acm212228-tbl-0003){ref-type="table-wrap"}, [4](#acm212228-tbl-0004){ref-type="table-wrap"}) {#acm212228-sec-0004}
==========================================================================================================================================================================================================================

 {#acm212228-sec-0005}

###### 

Daily quality control tests

  Designator   Test                                      Performance   
  ------------ ----------------------------------------- ------------- ----
  Daily                                                                
  DK1          kVp and mA indicators                     Functional    
  DK2          Beam‐off at key‐off test                  Functional    
  DK3          Beam interrupt                            Functional    
  DK4          Backup timer/monitor unit channel check   1%            2%
  DK5          Dosimetric test: output check             2%            4%

John Wiley & Sons, Ltd

Notes on daily testsDK1Functional check of kVp and mA indicatorsDK2Functional check of beam‐off at key‐offDK3Functional check of the beam interrupt button (radiation stop and restart when the radiation on button is pressed again)DK4Quantitative verification of correct operation of backup timer or backup monitor unitDK5Quantitative dosimetric test: output reproducibility test at the chosen energies and filter combinations. If the output is stable with time, this test can be done weekly (so replaced by WK4 according to Table [2](#acm212228-tbl-0002){ref-type="table-wrap"}) on the condition that there are documents and reports to support it

###### 

Weekly quality control tests

  Designator   Test                                             Performance   
  ------------ ------------------------------------------------ ------------- ----
  Weekly                                                                      
  WK1          Couch movement and brakes                        Functional    
  WK2          Unit motions and motion stops                    Functional    
  WK3          Interlocks for added filters/kVp‐filter choice   Functional    
  WK4          Dosimetric test: output check                    2%            4%

John Wiley & Sons, Ltd

Notes on weekly testsWK1Functional check of couch motion and brakes (where applicable)WK2Functional check of unit motions and motion stopsWK3Functional check of interlocks for added filters, correct placement of filters, and the matching of filters with kVp valueWK4Quantitative dosimetric test: output reproducibility test for all energies. This test can be limited to the energies used clinically on the condition that any additional energies cannot be chosen at any time (by removing the corresponding filters from the treatment room, for example)

###### 

Monthly quality control tests

  Designator   Test                                                                  Performance   
  ------------ --------------------------------------------------------------------- ------------- ------
  Monthly                                                                                          
  MK1          Mechanical stability and safety                                       Functional    
  MK2          Cone/filters integrity and cone indicators                            Functional    
  MK3          Physical distance indicators                                          2 mm          3 mm
  MK4          Accuracy of head tilt and rotation readouts                           1°            1.5°
  MK5          Light/x ray field coincidence                                         2 mm          3 mm
  MK6          Light field size                                                      2 mm          3 mm
  MK7          X ray field size indicator                                            2 mm          3 mm
  MK8          X ray field uniformity                                                5%            8%
  MK9          Output verification and reproducibility with head tilt and rotation   2%            4%
  MK10         Timer accuracy verification                                           1%            2%
  MK11         Dose rate output constancy                                            2%            4%
  MK12         Records                                                               Complete      

John Wiley & Sons, Ltd

Notes on monthly testsMK1Verification that the unit and accessories are firmly anchored and may be used without endangering patients or staffMK2Verification of the integrity of the filters and cones and cone indicatorsMK3Verification of the optical and/or mechanical distance indicator if the unit is equipped with oneMK4Verification of the angle readoutsMK5Performance parameters refer to agreement at each edge. This test does not apply to all machine designsMK6Geometric test to verify the light field sizes (where applicable)MK7Confirmation of radiation field size when a variable collimation system is provided. At least two field sizes must be checkedMK8Using a film, the flatness and symmetry of the X ray beam must be assessed for the largest coneMK9Quantitative dosimetric test: output reproducibility test at all energies with varying head tilt and rotation[27](#acm212228-bib-0027){ref-type="ref"}MK10If the unit is equipped with a timer, its accuracy must be checked against a stop watch over a range of doses of 10−1000 cGyMK11Should be checked for all beam qualities for MU‐based systemsMK12Documentation relating to the daily quality control checks, preventive maintenance, service calls and subsequent checks must be complete, legible, and the operator identified

###### 

Annual quality control tests

  Designator   Test                                          Performance                 
  ------------ --------------------------------------------- --------------------------- -----------
  Annual                                                                                 
  AK1          Reference dosimetry                           1%                          2%
  AK2          Timer and end‐effect error                    Characterize                ±0.05 min
  AK3          Output linearity                              n/a                         1%
  AK4          Output reproducibility                        2%                          3%
  AK5          Output error associated with beam interrupt   2%                          4%
  AK6          Beam quality                                  10%                         15%
  AK7          Alignment of focal spots                      0.5 mm                      1 mm
  AK8          Focal spot size                               Reproducible                
  AK9          Percentage depth dose verification            Characterize and document   
  AK10         Profiles verification                         Characterize and document   
  AK11         Independent quality control review            Complete                    

John Wiley & Sons, Ltd

Notes on annual testsAK1Using a high‐quality dosimetry system calibrated against the local secondary standard, all beams and cones in use are recalibratedAK2Timer and end‐effect error measurement may be performed in conjunction with AK3AK3Output linearity measurement for a clinically used filter/cone combination at a standard SSD and a dose range of 10−1000 cGyAK4Output reproducibility verification for a clinically used filter/cone combination. These measurements should be repeated at typical tilt and head rotation used for treatmentsAK5Output error when the beam is interrupted during the irradiation for a clinically used filter/cone combinationAK6The HVL of any clinically used beams is measured. The HVLs measured in millimeters of Al or millimeters of Cu as appropriate are compared with the values obtained at commissioning. These tolerances acknowledge measurement uncertaintyAK7Focal spot---quantitative measurement, assessed relative to acceptance test value where applicableAK8Using a pin hole or resolution toolAK9Verification of percentage depth dose measurements for all used filter/cone combinations against baselineAK10Verification of inplane and crossplane profiles at different depths for all used filter/cone combinations against baselineAK11To ensure redundancy and adequate monitoring, a second qualified medical physicist must independently verify the implementation, analysis, and interpretation of the quality control tests at least annually
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